搜索临床试验以:注射用多西紫杉醇(白蛋白结合型)
总计2766个结果
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Tianjin Medical University Cancer Institute and...招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.暂停
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 转移性乳腺癌 | 局部晚期乳腺癌美国
-
Gruppo Oncologico Italiano di Ricerca Clinica完全的
-
University of WashingtonNational Cancer Institute (NCI); Celgene Corporation完全的
-
Hoffmann-La Roche完全的
-
Anne NoonanNational Cancer Institute (NCI)招聘中
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Mayo ClinicNational Cancer Institute (NCI)撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
Huazhong University of Science and Technology主动,不招人
-
Fundacion Clinic per a la Recerca Biomédica尚未招聘
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang University尚未招聘
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Institut fuer FrauengesundheitEisai GmbH招聘中
-
The Third Affiliated hospital of Zhejiang Chinese...Zhejiang University招聘中
-
Kaiser PermanenteCelgene Corporation完全的
-
Southeastern Gynecologic OncologyCelgene Corporation完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
Tianjin Medical University Cancer Institute and...招聘中
-
Gruppo Oncologico Italiano di Ricerca ClinicaIstituto Toscano Tumori; Temas srl; Clirest s.r.l.; Mipharm S.p.A.未知
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的